Comparison Table: Some Drugs for Maintenance Treatment of Opioid Use Disorder (online only)

The Medical Letter on Drugs and Therapeutics

ONLINE
ONLY
ARTICLE

September 4, 2023

View Complete Issue Table of Contents 2019

Download PDF: US English

Disclosures & Objectives Disclosures & Objectives

Show Related
Terms Hide Related
Terms

View Complete Issue

Send Article Feedback

Med Lett Drugs Ther. 2023 Sep 4;65(1684):e144-5 doi:10.58347/tml.2023.1684b

Disclosures

Principal Faculty

Mark Abramowicz, M.D., President has disclosed no relevant financial relationships.
Jean-Marie Pflomm, Pharm.D., Editor in Chief has disclosed no relevant financial relationships.
Brinda M. Shah, Pharm.D., Consulting Editor has disclosed no relevant financial relationships.

Additional Contributor(s)

Michael Viscusi, Pharm.D., Associate Editor has disclosed no relevant financial relationships.

Objective(s)

Upon completion of this activity, the participant will be able to:

Explain the current approach to treatment of opioid use disorder.
Discuss the pharmacological options available for treatment of opioid use disorder and compare them based on their efficacy, safety, potential drug interactions, and availability.
Determine the best course of treatment for an individual patient with opioid use disorder.

Select a term to see related articles Brixadi buprenorphine methadone naloxone naltrexone opioid use disorder Sublocade Suboxone Vivitrol Zubsolv

View Comparison Table: Some Drugs for Maintenance Treatment of Opioid Use Disorder
Download PDF: US English | Canadian-English

The Medical Letter, Inc. does not warrant that all the material in this publication is accurate and complete in every respect. The Medical Letter, Inc. and its editors shall not be held responsible for any damage resulting from any error, inaccuracy, or omission.

This article has been freely provided.